Sign up to save your podcasts
Or
Share 'Game Changer': Treat Diabetes and Also Reduce CV Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
'Game Changer': Treat Diabetes and Also Reduce CV Risk
Drs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to 'be aware.'
View all episodes
By MedscapeDrs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to 'be aware.'